著者 Hobara, Narumi| Goda, Mitsuhiro| Yoshida, Namika| Takatori, Shingo| Kitamura, Yoshihisa| Mio, Mitsunobu| Kawasaki, Hiromu|
発行日 2008-05-28
出版物タイトル Neuroscience
150巻
3号
資料タイプ 学術雑誌論文
フルテキストURL fulltext.pdf
著者 Ushio, Soichiro| Wada, Yudai| Nakamura, Mizuki| Matsumoto, Daiki| Hoshika, Kota| Shiromizu, Shoya| Iwata, Naohiro| Esumi, Satoru| Kajizono, Makoto| Kitamura, Yoshihisa| Sendo, Toshiaki|
キーワード anxiolytic inflammation immunomodulation macrophages Kampo medicine
発行日 2022-08-12
出版物タイトル Frontiers In Pharmacology
13巻
出版者 Frontiers Media S.A.
開始ページ 890048
ISSN 1663-9812
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Ushio, Wada, Nakamura, Matsumoto, Hoshika, Shiromizu, Iwata, Esumi, Kajizono, Kitamura and Sendo.
論文のバージョン publisher
PubMed ID 36034871
DOI 10.3389/fphar.2022.890048
Web of Science KeyUT 000860773600001
関連URL isVersionOf https://doi.org/10.3389/fphar.2022.890048
JaLCDOI 10.18926/AMO/52893
フルテキストURL 68_5_255.pdf
著者 Esumi, Satoru| Kawasaki, Yoichi| Gomita, Yutaka| Kitamura, Yoshihisa| Sendo, Toshiaki|
抄録 Motivation incorporates several psychological aspects that produce reward-related and learning behaviors. Although reward-related behavior is reported to be mediated by the dopaminergic reward pathway, the involvement of dopaminergic systems in motivated behavior has not been fully clarified. Several experimental methodologies for motivational behavior have been reported, but pharmacological characteristics seem to vary among these methodologies. In this review, we attempt to summarize three main concepts:(1) the relationship of dopamine neuron physiology with motivated behavior, (2) the pharmacological characteristics of the runway intracranial self-stimulation model, and (3) the behavioral distinction of disparate motivated behaviors.
キーワード motivation reward dopamine operant behavior intracranial self-stimulation
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2014-10
68巻
5号
出版者 Okayama University Medical School
開始ページ 255
終了ページ 262
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2014 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 25338481
Web of Science KeyUT 000343269300001
フルテキストURL fulltext.pdf
著者 Kitamura, Yoshihisa| Akiyama, Kozue| Kitagawa, Kouhei| Shibata, Kazuhiko| Kawasaki, Hiromu| Suemaru, Katsuya| Araki, Hiroaki| Sendo, Toshiaki| Gomita, Yutaka|
キーワード Imipramine Carbamazepine ACTH 5-HT2A receptor Forced swim test Wet-dog shakes Treatment–resistant
備考 Published with permission from the copyright holder.
This is a author's copy,as published in Pharmacology Biochemistry and Behavior , 2008, volume 89, issue 3, pp235-240.
|
発行日 2008-05-20
出版物タイトル Pharmacology Biochemistry and Behavior
89巻
3号
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
DOI 10.1016/j.pbb.2007.12.015
Web of Science KeyUT 000255311600001
JaLCDOI 10.18926/AMO/61215
フルテキストURL 74_6_545.pdf
著者 Tatebe, Yasuhisa| Kanamitsu, Kiichiro| Kanzaki, Hirotaka| Ishida, Hisashi| Fujiwara, Kaori| Washio, Kana| Kitamura, Yoshihisa| Sendo, Toshiaki| Shimada, Akira| Tsukahara, Hirokazu|
抄録 Polymorphisms in methotrexate transporter pathways have been associated with methotrexate toxicities and clearance. Recent genome-wide association studies have revealed that the SLCO1B1 T521C variant is associated with methotrexate elimination. We present a case of a pediatric patient with acute lymphoblastic leukemia who suffered from persistently high plasma methotrexate concentrations and acute kidney injuries after the admin-istration of a medium dose of methotrexate. Subsequent genetic analysis showed that he was a carrier of dys-functional genetic variants associated with methotrexate clearance. This case highlights that polymorphisms of methotrexate transporter pathways can adversely affect methotrexate elimination in a clinically significant manner.
キーワード methotrexate polymorphism drug elimination acute kidney injury acute lymphoblastic leukemia
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-12
74巻
6号
出版者 Okayama University Medical School
開始ページ 545
終了ページ 550
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 33361876
Web of Science KeyUT 000601203600012
NAID 120006948942
フルテキストURL fulltext.pdf
著者 Masaoka, Yasuyuki| Kawasaki, Yoichi| Kikuoka, Ryo| Ogawa, Atsushi| Esumi, Satoru| Wada, Yudai| Ushio, Soichiro| Kitamura, Yoshihisa| Sendo, Toshiaki|
キーワード Valganciclovir Simple suspension method Stability HPLC Gavage tube
発行日 2020-07-07
出版物タイトル Journal of Pharmaceutical Health Care and Sciences
6巻
1号
出版者 BMC
開始ページ 16
ISSN 2055-0294
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s). 2020
論文のバージョン publisher
PubMed ID 32655872
DOI 10.1186/s40780-020-00172-w
Web of Science KeyUT 000549139200001
関連URL isVersionOf https://doi.org/10.1186/s40780-020-00172-w
フルテキストURL fulltext.pdf
著者 Isooka, Nami| Miyazaki, Ikuko| Kikuoka, Ryo| Wada, Kouichi| Nakayama, Erika| Shin, Kotaro| Yamamoto, Daichi| Kitamura, Yoshihisa| Asanuma, Masato|
キーワード Astrocyte Dopamine agonist Metallothionein Parkinson's disease Rotigotine Serotonin 1A receptor
発行日 2020-01-31
出版物タイトル Neurochemistry International
132巻
出版者 Elsevier
開始ページ 104608
ISSN 01970186
NCID AA0032399X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2019 The Authors. Published by Elsevier Ltd.
論文のバージョン publisher
PubMed ID 31765686
DOI 10.1016/j.neuint.2019.104608
Web of Science KeyUT 000508747200014
関連URL isVersionOf https://doi.org/10.1016/j.neuint.2019.104608
JaLCDOI 10.18926/AMO/67197
フルテキストURL 78_3_227.pdf
著者 Wada, Yudai| Ushio, Soichiro| Kitamura, Yoshihisa| Zamami, Yoshito| Sendo, Toshiaki|
抄録 Zolpidem, a non-benzodiazepine hypnotic, is primarily used to treat insomnia. In a previous study, pior treatment with non-benzodiazepine receptor agonists was associated with inflammation. The present study aimed to clarify the association between the effects of zolpidem and inflammation in mice treated with lipopolysaccharide (LPS), a known model of inflammation. We assessed the zolpidem-induced loss of righting reflex (LORR) duration 24 h after LPS treatment in mice. Additionally, the expressions of γ-aminobutyric acid (GABA)A receptor subunit and K+-Cl− cotransporter isoform 2 (KCC2) mRNA in the hippocampus and frontal cortex were examined in LPS-treated mice. Pretreatment with LPS was associated with significantly prolonged duration of zolpidem-induced LORR compared to control mice. This effect was significantly attenuated by administering bicuculline, a GABAA receptor antagonist, or flumazenil, a benzodiazepine receptor antagonist, in LPS-treated mice. Compared to controls, LPS-treated mice showed no significant change in the expression of GABAA receptor subunits in the hippocampus or frontal cortex. Bumetanide, an Na+-K+-2Cl− cotransporter isoform 1 blocker, attenuated the extended duration of zolpidem-induced LORR observed in LPS-treated mice. LPS significantly decreased Kcc2 mRNA expression in the hippocampus and the frontal cortex. These findings suggest that inflammation increases zolpidem-induced LORR, possibly through a reduction in KCC2 expression.
キーワード lipopolysaccharide zolpidem GABAA receptor K+-Cl− cotransporters
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2024-06
78巻
3号
出版者 Okayama University Medical School
開始ページ 227
終了ページ 235
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2024 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 38902210
Web of Science KeyUT 001267351000003
JaLCDOI 10.18926/AMO/40129
フルテキストURL 64_4_219.pdf
著者 Doi, Maho| Miyazaki, Ikuko| Nagamachi, Tomoko| Shinomiya, Kazuaki| Matsunaga, Hisashi| Sendo, Toshiaki| Kawasaki, Hiromu| Asanuma, Masato| Gomita, Yutaka| Kitamura, Yoshihisa|
抄録 We examined the influence of chronic adrenocorticotropic hormone (ACTH) treatment on the number of Ki-67-positive cells in the dentate gyrus of the hippocampus in rats. ACTH treatment for 14 days decreased the number of such cells. The administration of imipramine or lithium alone for 14 days had no effect in saline-treated rats. The effect of ACTH was blocked by the administration of imipramine. Furthermore, the coadministration of imipramine and lithium for 14 days significantly increased the number of Ki-67-positive cells in both the saline and ACTH-treated rats. The coadministration of imipramine and lithium normalized the cell proliferation in the dentate gyrus of the hippocampus in rats treated with ACTH.
キーワード ACTH imipramine lithium proliferation Ki-67
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2010-08
64巻
4号
出版者 Okayama University Medical School
開始ページ 219
終了ページ 223
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 20802538
Web of Science KeyUT 000281384400002
フルテキストURL K0005463_other1.pdf
著者 Higuchi, Yuji | Uchitomi, Yosuke| Fujimori, Maiko| Koyama, Toshihiro| Kataoka, Hitomi| Kitamura, Yoshihisa| Sendo, Toshiaki| Inagaki, Masatoshi|
キーワード Empathy Hospital pharmacist Japan Pharmaceutical care
備考 The final publication is available at Springer| 岡山大学審査学位副論文|
発行日 2015-12
出版物タイトル International Journal of Clinical Pharmacy
37巻
6号
出版者 Springer
開始ページ 1258
終了ページ 1266
ISSN 2210-7703
NCID AA12633112
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン author
PubMed ID 26441314
DOI 10.1007/s11096-015-0204-2
Web of Science KeyUT 000363490100042
関連URL https://doi.org/10.1007/s11096-015-0204-2 http://ousar.lib.okayama-u.ac.jp/55016
フルテキストURL fulltext.pdf
著者 Hagiya, Hideharu| Koyama, Toshihiro| Zamami, Yoshito| Tatebe, Yasuhisa| Funahashi, Tomoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Hinotsu, Shiro| Sendo, Toshiaki| Rakugi, Hiromi| Kano, Mitsunobu R.|
キーワード adult intensive & critical care epidemiology geriatric medicine health & safety health policy public health
発行日 2019-12-11
出版物タイトル BMJ OPEN
9巻
12号
出版者 BMJ Publishing Group
開始ページ e033462
ISSN 2044-6055
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © Author(s) (or theiremployer(s)) 2019.
論文のバージョン publisher
PubMed ID 31831549
DOI 10.1136/bmjopen-2019-033462
Web of Science KeyUT 000512773400250
関連URL isVersionOf https://doi.org/10.1136/bmjopen-2019-033462
JaLCDOI 10.18926/AMO/60368
フルテキストURL 74_4_301.pdf
著者 Takahashi, Kei| Kitamura, Yoshihisa| Ushio, Soichiro| Sendo, Toshiaki|
抄録 Ketamine has been clinically proven to ameliorate depression, including treatment-resistant depression. The detailed mechanism of action of ketamine in treatment-resistant depression remains unclear. We examined the effects of ketamine on the immobility times of adrenocorticotropic hormone (ACTH)-treated rats during the forced swim test, and we explored the mechanism by which ketamine acts in this model. We investigated the neuroanatomical site of action by microinjecting ketamine into the medial prefrontal cortex of rats. A significant reduction of the rats’ immobility during the forced swim test was observed after the intraperitoneal injection of ketamine in both saline- and ACTH-treated rats. The microinjection of ketamine into the medial prefrontal cortex also decreased immobility during the forced swim test in both saline- and ACTH-treated rats. The immobility-decreasing effect of intraperitoneally injected ketamine was blocked by administering WAY100635, a 5-HT1A receptor antagonist, into the medial prefrontal cortex. These findings contribute to the evidence that ketamine can be useful against treatment-resistant depressive conditions. The immobility-reducing effects of ketamine might be mediated by 5-HT1A receptor activity in the medial prefrontal cortex.
キーワード ketamine adrenocorticotropic hormone forced swim test medial prefrontal cortex 5-HT1A receptor
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-08
74巻
4号
出版者 Okayama University Medical School
開始ページ 301
終了ページ 306
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32843761
Web of Science KeyUT 000562508700005
NAID 120006880207
JaLCDOI 10.18926/AMO/32092
フルテキストURL fulltext.pdf
著者 Kitamura, Yoshihisa| Araki, Hiroaki| Nagatani, Tadashi| Takao, Katsuyuki| Shibata, Kazuhiko| Gomita, Yutaka|
抄録

We studied the influence of imipramine on the duration of immobility in chronic forced-swim-stressed rats. Both single and chronic administration of imipramine potently shortened immobility in naive rats during forced-swim testing. However, chronic, 14-day forced-swim stress testing blocked the immobility-decreasing effect induced by a single administration of imipramine. When imipramine was administered for 14 days concurrently with forced-swim stress testing, immobility was shortened significantly. From the viewpoint of imipramine's effect, these findings suggest that chronic forced-swim stress testing in rats may be an effective animal model for depression.

キーワード stress depression imipramine forced-swim test animal model
Amo Type Article
出版物タイトル Acta Medica Okayama
発行日 2004-12
58巻
6号
出版者 Okayama University Medical School
開始ページ 271
終了ページ 274
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
論文のバージョン publisher
査読 有り
PubMed ID 15762295
Web of Science KeyUT 000225959100003
フルテキストURL fulltext.pdf
著者 Kikuoka, Ryo| Miyazaki, Ikuko| Kubota, Natsuki| Maeda, Megumi| Kagawa, Daiki| Moriyama, Masaaki| Sato, Asuka| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki| Asanuma, Masato|
発行日 2020-11-26
出版物タイトル Scientific Reports
10巻
1号
出版者 Nature Research
開始ページ 20698
ISSN 2045-2322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2020
論文のバージョン publisher
PubMed ID 33244123
DOI 10.1038/s41598-020-77652-4
Web of Science KeyUT 000596329600054
関連URL isVersionOf https://doi.org/10.1038/s41598-020-77652-4
JaLCDOI 10.18926/AMO/30940
フルテキストURL fulltext.pdf
著者 Sagara, Hidenori| Kitamura, Yoshihisa| Esumi, Satoru| Sendo, Toshiaki| Araki, Hiroaki| Gomita, Yutaka|
抄録

It is well known that priming stimulation promotes the motivational effects of intracranial self-stimulation(ICSS) behavior. An experimental methodology using the runway method could separately study the reward and motivational effects of ICSS behavior. In the present study, we examined the motivational effect of nicotine as measured by the runway method using priming stimulation of ICSS behavior. Electrodes were implanted chronically into the medial forebrain bundle (MFB) in rats. A lever for stimulation of the MFB was set on the opposite side of the start box in the apparatus, and rats were trained to get a reward stimulation (50-200 microA, 0.2 ms, 60 Hz) of MFB when the goal lever was pressed. After the rats were trained to press the lever, a priming stimulation of the MFB was performed. After receiving the priming stimulation, rats were placed at the start box of the runway apparatus, and the running time duration until the goal lever was pressed was measured. Subcutaneous injection of nicotine at a dose of 0.2mg/kg produced an increase in running speed to obtain the reward stimulation, and priming stimulation facilitated the motivational effect to obtain the electrical brain stimulation reward in the rats. These results suggest that nicotine significantly enhanced the motivational effect on ICSS behavior as determined using the runway method. The runway method using priming stimulation of ICSS behavior may become the new experimental methodology with which to measure the motivational effect of some drugs.

キーワード intracranial self-stimulation runway nicotine priming stimulation motivational effect
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2008-08
62巻
4号
出版者 Okayama University Medical School
開始ページ 227
終了ページ 233
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
論文のバージョン publisher
査読 有り
PubMed ID 18766205
Web of Science KeyUT 000258680900002
フルテキストURL fulltext.pdf
著者 Koyama, Toshihiro| Sasaki, Misato| Hagiya, Hideharu| Zamami, Yoshito| Funahashi, Tomoko| Ohshima, Ayako| Tatebe, Yasuhisa| Mikami, Naoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Sendo, Toshiaki| Hinotsu, Shiro| Kano, Mitsunobu R.|
発行日 2019-12-27
出版物タイトル Scientific Reports
9巻
出版者 Nature Publishing Group
開始ページ 20235
ISSN 2045-2322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2019
論文のバージョン publisher
PubMed ID 31882673
DOI 10.1038/s41598-019-56388-w
Web of Science KeyUT 000509351200002
関連URL isVersionOf https://doi.org/10.1038/s41598-019-56388-w
JaLCDOI 10.18926/AMO/51868
フルテキストURL 67_5_319.pdf
著者 Murakawa, Kiminaka| Sato, Tomoaki| Maeda, Yoshinobu| Kitamura, Yoshihisa| Tanimoto, Mitsune| Sendo, Toshiaki|
抄録 Graft-versus-host disease (GVHD) is a major concern in transplantation patients. Gut GVHD is accompanied by diarrhea, abdominal pain, and/or melena. Although oral treatment with corticosteroids (CSs) is effective in treating gut GVHD, it can cause adverse reactions that affect the entire body. Topical administration of CSs can be effective in treating diseases in which lesions are limited locally, because adverse reactions can then be alleviated. In this study, we examine and discuss an enteric-coated beclomethasone dipropionate (BDP) capsule (BDP-EC) formulated at Okayama University Hospital. The BDP-EC did not dissolve in solution 1 (pH1.2), and began disintegrating in solution 2 (pH6.8) after 5min, with a mean dissolution rate at 15min of 85%. We then used the capsule to treat a patient who developed gut GVHD after allogeneic hematopoietic stem cell transplantation. Clinically, the frequency of diarrhea decreased after BDP-EC administration. In addition, we were able to decrease the prednisolone equivalent dose. Symptoms associated with adverse reactions to BDP were not observed during the hospitalization period. These findings suggest that the administration of BDP-EC in the early stages of gut GVHD may allow a reduction in the initial doses of systemic CSs.
キーワード beclomethasone intestinal graft-versus-host disease enteric-coated capsule in-hospital formulation
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2013-10
67巻
5号
出版者 Okayama University Medical School
開始ページ 319
終了ページ 324
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2013 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 24145732
Web of Science KeyUT 000325836100006
フルテキストURL fulltext.pdf
著者 Asanuma, Masato| Okumura-Torigoe, Nao| Miyazaki, Ikuko| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki|
キーワード astrocyte neuroprotection region-specificity striatum mesencephalon oxidative stress 6-hydroxydopamine Nrf2 phase II detoxifying molecules
発行日 2019-01-30
出版物タイトル International Journal of Molecular Sciences
20巻
3号
出版者 MDPI
開始ページ 598
ISSN 1422-0067
NCID AA12038549
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン publisher
PubMed ID 30704073
DOI 10.3390/ijms20030598
Web of Science KeyUT 000462412500142
関連URL isVersionOf https://doi.org/10.3390/ijms20030598
JaLCDOI 10.18926/AMO/63410
フルテキストURL 76_2_167.pdf
著者 Higashionna, Tsukasa| Ushio, Soichiro| Esumi, Satoru| Murakawa, Kiminaka| Kitamura, Yoshihisa| Sendo, Toshiaki|
抄録 Febrile neutropenia (FN) is a serious side effect in patients undergoing cancer chemotherapy and frequently proves fatal. Since infection control is crucial in the management of FN, the antimicrobial agent cefozopran (CZOP) has been recommended but not approved for routine use in clinical care of FN in Japan. However, few studies of CZOP in the management of FN have used a thrice daily dose schedule. The aim of this study was to retrospectively compare the efficacy and safety of CZOP at a dose of 1 g three times daily to those of cefepime (CFPM) in the treatment of FN in our lung cancer patients. The response rates of the CZOP and CFPM groups were 89.5% (17/19 cases) and 83.0% (39/47 cases), respectively, with no significant difference between the two groups. The median duration of antimicrobial treatment was 6 days (4-10 days) in the CZOP group and 7 days (3-13 days) in the CFPM group, with no significant difference between groups. The incidence rates of adverse events were 21.1% (4/19 cases) in the CZOP group and 19.1% (9/47 cases) in the CFPM group. No adverse events of Grade 3 or higher were observed in either group. The findings of the present study suggest that CZOP administration at a dose of 1 g three times per day as an antimicrobial treatment alternative against FN.
キーワード febrile neutropenia cefozopran cefepime lung cancer retrospective
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-04
76巻
2号
出版者 Okayama University Medical School
開始ページ 167
終了ページ 172
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 35503444
Web of Science KeyUT 000792374900008
JaLCDOI 10.18926/AMO/32879
フルテキストURL fulltext.pdf
著者 Umeda, Yuichi| Amano, Manabu| Suemaru, Katsuya| Yamaguchi, Takumi| Kitamura, Yoshihisa| Gomita, Yutaka| Kawasaki, Hiromu| Araki, Hiroaki|
抄録

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hyperglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexamethasone and streptozotocin. ACTH (100 μg/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.) and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats. The wet-dog shake responses induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 5-HT2A receptors under the condition of hyperactivity of the HPA axis.

キーワード hyperglycemia ACTH dexamethasone streptozotocin 5-HT2A receptor
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2007-12
61巻
6号
出版者 Okayama University Medical School
開始ページ 311
終了ページ 317
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
論文のバージョン publisher
査読 有り
PubMed ID 18183075
Web of Science KeyUT 000251943800001